Regarding laboratory data, CKD patients with subclinical atherosclerosis presented higher levels of glucose, UAE, and IL6, and reduced serum concentrations of Klotho as well as lower mRNA expression levels in PBCs. Here, KL is linked to chronic kidney disease.